Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00553306
Recruitment Status : Completed
First Posted : November 5, 2007
Last Update Posted : February 15, 2017
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : March 2012
  Certification/Extension First Submitted : February 13, 2017